Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page displays the completed NCT02684253 clinical trial record, including its eligibility criteria, treatment arms, outcome measures, results, publication, and study documents.SummaryDifference53%

- Check16 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than the study details.SummaryDifference0.2%

- Check30 days agoChange DetectedAn NIH-wide notice about changing terminology was added above the error page, and the site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the full study record, indicating that access to the page is blocked and no study details are displayed.SummaryDifference19%

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.